Drug Type Small molecule drug |
Synonyms CP006 |
Action agonists, antagonists |
Mechanism GR agonists(Glucocorticoid receptor agonists), mAChRs antagonists(Muscarinic acetylcholine receptor antagonists), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC29H34BrNO2 |
InChIKeyPEJHHXHHNGORMP-UHFFFAOYSA-M |
CAS Registry869113-09-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 1 | China | 14 Nov 2024 | |
Pulmonary Disease, Chronic Obstructive | IND Approval | China | 02 Feb 2024 |
Phase 4 | 581 | (Symbicort Turbuhaler + Ipratropium + Theophylline SR) | uakvxgxnbd(ckfojwwbte) = iraqqeqbgb klyoroxdib (nkjjkjsahd, vayryodvjg - iipimrqmtz) View more | - | 26 Aug 2014 | ||
(Ipratropium + Theophylline SR) | uakvxgxnbd(ckfojwwbte) = wzuvatewot klyoroxdib (nkjjkjsahd, fnymyplfoj - cetqvnahro) View more |